{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T11:58:14Z","timestamp":1771847894495,"version":"3.50.1"},"reference-count":39,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hereditary hemochromatosis (HH) due to homozygosity for the C282Y mutation in the HFE gene is a common inherited iron overload disorder in whites of northern European descent. Hepcidin deficiency, the hallmark of the disorder, leads to dysregulated intestinal iron absorption and progressive iron deposition in the liver, heart, skin, endocrine glands, and joints. Survival is normal if organ damage is prevented by early institution of phlebotomy therapy. HH arthropathy is the symptom most affecting quality of life and can be debilitating. Genotype screening in large population studies has shown that the clinical penetrance of C282Y homozygosity is highly variable and can be very low, with up to 50% of women and 20% of men showing a silent phenotype. Targeted population screening for the HFE C282Y mutation is not recommended at present, but might be reconsidered as a cost-effective approach to management if counseling and care were better organized and standardized. Referral of patients to the blood center for phlebotomy therapy and use of HH donor blood for transfusion standardizes treatment, minimizes treatment costs, and may benefit society as a whole. Physician practices should be amended such that HH subjects are more frequently referred to the blood center for therapy.<\/jats:p>","DOI":"10.1182\/asheducation-2013.1.645","type":"journal-article","created":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T15:51:13Z","timestamp":1386345073000},"page":"645-650","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Hemochromatosis: the new blood donor"],"prefix":"10.1182","volume":"2013","author":[{"given":"Susan F.","family":"Leitman","sequence":"first","affiliation":[{"name":"Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"2","key":"2019111705315723500_B1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood-2007-12-077388","article-title":"Forging a field: the golden age of iron biology","volume":"112","author":"Andrews","year":"2008","journal-title":"Blood"},{"issue":"4","key":"2019111705315723500_B2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng0896-399","article-title":"A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis","volume":"13","author":"Feder","year":"1996","journal-title":"Nat Genet"},{"issue":"9346","key":"2019111705315723500_B3","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(02)11607-2","article-title":"Genetics of haemochromatosis","volume":"360","author":"Bomford","year":"2002","journal-title":"Lancet"},{"issue":"9602","key":"2019111705315723500_B4","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(07)61782-6","article-title":"Haemochromatosis","volume":"370","author":"Adams","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"2019111705315723500_B5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/GIM.0b013e31819d30f2","article-title":"HFE-associated hereditary hemochromatosis","volume":"11","author":"Alexander","year":"2009","journal-title":"Genet Med"},{"issue":"1","key":"2019111705315723500_B6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hep.1840110122","article-title":"The pathology of hepatic iron overload: a free radical-mediated process?","volume":"11","author":"Bacon","year":"1990","journal-title":"Hepatology"},{"issue":"25","key":"2019111705315723500_B7","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1073\/pnas.0503804102","article-title":"The molecular basis of ferroportin\u2013linked hemochromatosis","volume":"102","author":"De Domenico","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2019111705315723500_B8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/10906570050114867","article-title":"Uncommon mutations and polymorphisms in the hemochromatosis gene","volume":"4","author":"Pointon","year":"2000","journal-title":"Genet Test"},{"key":"2019111705315723500_B9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-med-050109-142444","article-title":"Hepcidin and disorders of iron metabolism","volume":"62","author":"Ganz","year":"2011","journal-title":"Annu Rev Med"},{"issue":"3","key":"2019111705315723500_B10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1055\/s-0031-1286059","article-title":"The molecular pathogenesis of hereditary hemochromatosis","volume":"31","author":"Babitt","year":"2011","journal-title":"Semin Liver Dis"},{"issue":"5704","key":"2019111705315723500_B11","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"issue":"17","key":"2019111705315723500_B12","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJMoa041534","article-title":"Hemochromatosis and iron-overload screening in a racially diverse population","volume":"352","author":"Adams","year":"2005","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111705315723500_B13","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1056\/NEJM199909023411002","article-title":"A population-based study of the clinical expression of the hemochromatosis gene","volume":"341","author":"Olynyk","year":"1999","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111705315723500_B14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archinte.166.3.294","article-title":"Screening for hemochromatosis in asymptomatic subjects with or without a family history","volume":"166","author":"Powell","year":"2006","journal-title":"Arch Intern Med"},{"issue":"2","key":"2019111705315723500_B15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-127-2-199707150-00002","article-title":"Clinical features of genetic hemochromatosis in women compared with men","volume":"127","author":"Moirand","year":"1997","journal-title":"Ann Intern Med"},{"issue":"4","key":"2019111705315723500_B16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cgh.2011.11.032","article-title":"Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 ug\/L at diagnosis","volume":"10","author":"Barton","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"2019111705315723500_B17","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1046\/j.1537-2995.2003.00570.x","article-title":"Hemochromatosis subjects as allogeneic blood donors: a prospective study","volume":"43","author":"Leitman","year":"2003","journal-title":"Transfusion"},{"issue":"20","key":"2019111705315723500_B18","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM198511143132004","article-title":"Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis","volume":"313","author":"Niederau","year":"1985","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111705315723500_B19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa073286","article-title":"Iron-overload-related disease in HFE hereditary hemochromatosis","volume":"358","author":"Allen","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111705315723500_B20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/art.30094","article-title":"Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load","volume":"63","author":"Carroll","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"s3","key":"2019111705315723500_B21","first-page":"14A","article-title":"Risk of total joint arthroplasty in patients with C282Y-homozygous hemochromatosis","volume":"49","author":"Wehbe","year":"2009","journal-title":"Transfusion"},{"issue":"3","key":"2019111705315723500_B22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1056\/NEJMe078215","article-title":"Clinical penetrance of hereditary hemochromatosis","volume":"358","author":"Bacon","year":"2008","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111705315723500_B23","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1182\/blood-2007-11-122374","article-title":"Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis","volume":"111","author":"Wood","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111705315723500_B24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/hep.22972","article-title":"HFE C282Y\/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity","volume":"50","author":"Gurrin","year":"2009","journal-title":"Hepatology"},{"issue":"7","key":"2019111705315723500_B25","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cgh.2006.04.013","article-title":"Liver diseases in the hemochromatosis and iron overload screening study","volume":"4","author":"Adams","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"2019111705315723500_B26","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1046\/j.1537-2995.2001.41060819.x","article-title":"MCV as a guide to phlebotomy therapy for hereditary hemochromatosis","volume":"41","author":"Bolan","year":"2001","journal-title":"Transfusion"},{"issue":"9302","key":"2019111705315723500_B27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(02)07447-0","article-title":"Penetrance of the 845G to A (C282Y) HFE hereditary haemochromatosis mutation in the USA","volume":"359","author":"Beutler","year":"2002","journal-title":"Lancet"},{"issue":"10","key":"2019111705315723500_B28","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1080\/003655201750422747","article-title":"Screening for hemochromatosis-high prevalence and low morbidity in an unselected population of 65,238 persons","volume":"36","author":"Asberg","year":"2001","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"2019111705315723500_B29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1478-3231.2008.01661.x","article-title":"Asymptomatic individuals at genetic risk of haemochromatosis take appropriate steps to prevent disease related to iron overload","volume":"28","author":"Allen","year":"2008","journal-title":"Liver International"},{"issue":"2","key":"2019111705315723500_B30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/gast.2002.30992","article-title":"Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis","volume":"122","author":"Fletcher","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"2019111705315723500_B31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-149-4-200808190-00009","article-title":"Hereditary hemochromatosis: time for targeted screening","volume":"149","author":"Phatak","year":"2008","journal-title":"Ann Intern Med"},{"issue":"1","key":"2019111705315723500_B32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00000441-199101000-00005","article-title":"A history of phlebotomy therapy for hemochromatosis","volume":"301","author":"Crosby","year":"1991","journal-title":"Am J Med Sci"},{"issue":"2","key":"2019111705315723500_B33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.21260","article-title":"Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases","volume":"44","author":"Falize","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"2019111705315723500_B34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.24330","article-title":"Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Bacon","year":"2011","journal-title":"Hepatology"},{"key":"2019111705315723500_B35","unstructured":"Center for Biologics Evaluation and Research\n          Guidance for industry: variances for blood collection from individuals with hereditary hemochromatosis\n          Accessed May 13, 2013\n          Available from: http:\/\/www.fda.gov\/biologicsbloodvaccines\/guidancecomplianceregulatoryinformation\/guidances\/blood\/ucm076719.htm"},{"issue":"10","key":"2019111705315723500_B36","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.0041-1132.2004.00420_1.x","article-title":"Hemochromatosis blood donor programs: marginal for the red blood cell supply but potentially good for patient care","volume":"44","author":"Newman","year":"2004","journal-title":"Transfusion"},{"issue":"11","key":"2019111705315723500_B37","first-page":"779","article-title":"Repeated isovolemic large-volume erythrocytapheresis in the treatment of idiopathic hemochromatosis","volume":"30","author":"Kellner","year":"1992","journal-title":"Gastroenterology"},{"issue":"6","key":"2019111705315723500_B38","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1572-0241.1999.1120_f.x","article-title":"Screening blood donors for hereditary hemochromatosis: decision analysis model comparing genotyping to phenotyping","volume":"94","author":"Adams","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"2019111705315723500_B39","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/j.1572-0241.1999.1430_w.x","article-title":"Screening for hemochromatosis: phenotyping or genotyping or both?","volume":"94","author":"Tavill","year":"1999","journal-title":"Am J Gastroenterol"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2013\/1\/645\/1250157\/bep00113000645.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2013\/1\/645\/1250157\/bep00113000645.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T10:32:19Z","timestamp":1573986739000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2013\/1\/645\/20817\/Hemochromatosis-the-new-blood-donor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,6]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12,6]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2013.1.645","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,6]]}}}